Concepedia

Publication | Open Access

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data

110

Citations

36

References

2023

Year

Abstract

The results reported in this first real-world analysis mostly confirmed the results achieved in the TOPAZ-1 trial in terms of PFS, ORR and safety.

References

YearCitations

Page 1